CHANG NANCY T
Known title: DirectorCIK: 0001135041
Associated companies
Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
September 29, 2026
IMMX Holds Shareholder and Analyst Call. Immix Biopharma hosted a shareholder and analyst conference call, sharing recent company updates and answering questions. The discussion gave participants insight into the company's current activities and outlook. Such calls can influence how investors view the business and its progress.
Transaction History
| WTI | ▼ Sell | Open Market | 60,000 | $199K | 7/15/2026 | View on chart |
| WTI | ▲ Buy | Option Exercise | 103,448 | — | 6/3/2026 | View on chart |
| IMMX | ▲ Buy | Grant | 6,250 | $0 | 5/22/2026 | View on chart |
| WTI | ▲ Buy | Option Exercise | 73,892 | — | 6/3/2025 | View on chart |
| WTI | ▲ Buy | Option Exercise | 38,760 | — | 6/17/2024 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 8, 2026
W&T Offshore Converts Credit Facility to Reserve-Based Lending
W&T Offshore has converted its revolving credit facility into a reserve‑based lending structure. This change provides the company with greater flexibility to draw on credit as needed, potentially easing future financing costs. The move is a routine corporate action that may support the company’s ongoing operations.
W&T Offshore Converts Credit Facility to Reserve-Based Lending. W&T Offshore has converted its revolving credit facility into a reserve‑based lending structure. This change provides the company with greater flexibility to draw on credit as needed, potentially easing future financing costs. The move is a routine corporate action that may support the company’s ongoing operations.